<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Géraldine de Muylder</style></author><author><style face="normal" font="default" size="100%">Valeska Laisnez</style></author><author><style face="normal" font="default" size="100%">Giulietta Stefani</style></author><author><style face="normal" font="default" size="100%">Caroline Boulouffe</style></author><author><style face="normal" font="default" size="100%">Faes, Christel</style></author><author><style face="normal" font="default" size="100%">Hammami, Naïma</style></author><author><style face="normal" font="default" size="100%">Pierre Hubin</style></author><author><style face="normal" font="default" size="100%">Molenberghs, Geert</style></author><author><style face="normal" font="default" size="100%">Jasper Sans</style></author><author><style face="normal" font="default" size="100%">van de Konijnenburg, Cecile</style></author><author><style face="normal" font="default" size="100%">Stefaan Van der Borght</style></author><author><style face="normal" font="default" size="100%">Ruben Brondeel</style></author><author><style face="normal" font="default" size="100%">Jorgen Stassijns</style></author><author><style face="normal" font="default" size="100%">Tinne Lernout</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Translating the COVID-19 epidemiological situation into policies and measures: the Belgian experience.</style></title><secondary-title><style face="normal" font="default" size="100%">Front Public Health</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">HEALTH POLICY</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Pandemics</style></keyword><keyword><style  face="normal" font="default" size="100%">public health</style></keyword><keyword><style  face="normal" font="default" size="100%">Risk Assessment</style></keyword><keyword><style  face="normal" font="default" size="100%">SARS-CoV-2</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;The COVID-19 pandemic led to sustained surveillance efforts, which made unprecedented volumes and types of data available. In Belgium, these data were used to conduct a targeted and regular assessment of the epidemiological situation. In addition, management tools were developed, incorporating key indicators and thresholds, to define risk levels and offer guidance to policy makers. Categorizing risk into various levels provided a stable framework to monitor the COVID-19 epidemiological situation and allowed for clear communication to authorities. Although translating risk levels into specific public health measures has remained challenging, this experience was foundational for future evaluation of the situation for respiratory infections in general, which, in Belgium, is now based on a management tool combining different data sources.&lt;/p&gt;
</style></abstract></record></records></xml>